Citi has initiated coverage of Viking Therapeutics (NASDAQ:VKTX) with a neutral rating, citing the need for more data for its weight-loss drug candidate VK2735 and high barriers to entry. The ...

Citi has downgraded Nike Inc.’s stock to neutral from buy, citing the challenges facing the sneaker maker as it attempts to ...

Citi no longer has confidence in Nike's ability to deliver a turnaround. Its analyst says he wasn't reassured after a meeting ...

Financial services, and especially financial advising, have historically been male dominated, but Nigerian women’s financial ...

Beth Kowitt is a Bloomberg Opinion columnist covering corporate America. She was previously a senior writer and editor at ...

Hershey's outlook for FY25 remains positive despite rising cocoa prices, with potential upside drivers outweighing risks, ...

The New York Mets reunited with their star first baseman in Pete Alonso. What could the opening day lineup look like with ...

Citi raised the firm’s price target on Monolithic Power (MPWR) to $800 from $700 and keeps a Buy rating on the shares. The company reported ...

Trane Technologies plc (NYSE: TT) a global climate innovator, today announced that company leadership will participate in a ...

Pagaya CEO Gal Krubiner expressed confidence in the company's robust funding program, highlighting its role in the expansion of the U.S. lending ecosystem. Ivan Zinn, Head of Alternative Credit at ...

Citi lowered the firm’s price target on Amazon.com (AMZN) to $273 from $275 and keeps a Buy rating on the shares. The firm is “incrementally ...

Investment banking firm Singhi Advisors has appointed former Barclays and Citi executive Atal Agarwal as a partner to ...